First among equals: the cancer cell hierarchy

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Cancer cells display varying proliferative capacities, a phenomenon explained by the cancer stem cell (CSC) model.
• This model posits that tumors comprise a small fraction of self-renewing CSCs and a larger population of their non-renewing progeny.
• The CSC model has significant implications for understanding and treating cancer.

Purpose of the Study:

• To explore the implications of the CSC model for cancer therapy.
• To highlight the critical role of CSC self-renewal propensity (Psr) in tumor curability.
• To introduce differentiation therapy as a strategy targeting CSC Psr.

Main Methods:

• Conceptual framework based on the CSC model.
• Analysis of the relationship between CSC frequency, Psr, and therapeutic outcomes.
• Definition and proposal of differentiation therapy.

Main Results:

• Eradication of CSCs is proposed as a necessary and sufficient condition for cancer cure.
• Tumor curability is directly influenced by the frequency of CSCs and their Psr.
• Small variations in CSC Psr can profoundly affect cancer therapy success rates.

Conclusions:

• The CSC model provides a framework for understanding cancer heterogeneity and therapeutic resistance.
• Targeting CSCs, specifically their self-renewal, is essential for achieving complete tumor eradication.
• Differentiation therapy, by reducing CSC Psr, offers a promising strategy for cancer treatment.